• Japanese
  • Korean
  • Chinese
Cover Image

DNA Probes-Based Diagnostics

Abstract

This report analyzes the worldwide markets for DNA Probes-based Diagnostics in US$ Million by the following application areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, Molecular HLA (Human Leukocyte Antigen) Typing, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 63 companies including many key and niche players such as Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson & Company, Beckman Coulter, Inc., bioMerieux, Celera Group, Gen-Probe Incorporated, Genzyme Corporation, Luminex Molecular Diagnostics, QIAGEN, Roche Diagnostics, and Siemens Healthcare Diagnostics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc. (GIA) is a reputed publisher of off-the-shelf market research. Recognized as one of the most consistently accurate forecasting company in the world, GIA currently serves more than 9,500 companies from 36 countries worldwide. The company was founded in 1987, initially recognized globally as a research boutique specializing in the medical industry. Over the past 25 years, the company expanded its coverage and now publishes extensively upon more than 180 major industries.

Our experienced team is dedicated to world-class research and analysis. We attribute our success to our people, their commitment and work culture.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Infectious Diseases
    • Cancer
    • Genetic Predisposition
    • Identity/Forensics
    • Molecular HLA Testing
    • Other Diagnostic Applications

II. EXECUTIVE SUMMARY

1. MARKET DYNAMICS

  • Industry Overview
  • DNA Probes: Robust Growth Ahead
  • Decoding the Genetic Puzzle
    • Advantages of DNA-Probe Tests
  • Growth Drivers in a Nutshell
  • Growth Inhibitors in a Nutshell
  • Genetic Profiling of Pathogens: A Road Less Traveled
    • Roche's Entry into the Hall of Molecular Fame
  • DNA Technology: An Evolutionary Scan
    • An Era of Excellence: Tracking Landmark Breakthroughs in DNA Diagnostics
  • Opportunities
  • Market Trends/Issues
  • DNA Tests: Finding Use in Numerous Applications
  • World's Aging Population Drives the Popularity of DNA-Probe Tests
  • Reimbursements: "Under the Umbrella"
  • Evolution of New & Virulent Infectious Agents
  • The Enlightened Consumer of the 21st Century
  • Challenges In Widespread Deployment of DNA Based Diagnostics
    • Miniaturization: An Uphill Task
    • Improvements in Assay Capabilities
    • Information Handling & Processing: The Soft Side of Diagnostics
    • Integration: The Ultimate Challenge
  • The United States: Unraveling the Country's Edge in DNA based Diagnostics

2. DNA PROBES-BASED DIAGNOSTICS - A PRIMER

  • Diagnostic Gene Detection Products
  • Molecular Diagnostics: A Powerful Disease Detection Tool
  • DNA Probes-Based Products
  • Direct Detection of Target Sequence
  • Nucleic Acid Amplification
  • Gene Detection Using DNA Chips
  • Gene Detection by DNA Sequencing
  • The Dynamics of Key Enabling Technologies
  • In Situ Hybridization
  • PCR: Polymerase Chain Reaction
  • Chemiluminescence
  • Gen-Probe Tigris
  • DNA Chips
  • Key Players
  • Players in Molecular Diagnostics Market
  • Molecular Diagnostics - A Primer
  • Implications for Clinical Diagnostics
  • Need of the Hour
  • Molecular Diagnostics: Marking the Convergence of Numerous Technologies
  • Impact of the Human Genome Project
  • Molecular Diagnostics: Domain of the Developed Countries
  • "Tailored Patient Management": An Epitomized Future of Molecular Diagnostics
  • Futuristics: A Rumination

3. PRODUCT OVERVIEW

  • Background
  • Gene Probe Technology
  • What is DNA?
  • DNA Probes
  • Miniaturization: A Revolutionary Method in DNA Analysis
  • Gene Chip Technology
  • DNA Chips
  • Chromosome Painting Probes
  • Diagnostic Applications Based on DNA Probes: An Overview
  • Infectious Diseases
    • Respiratory Tract Infections
      • Diagnosis of Mycoplasma
      • DNA Probes to Detect Legionella Pneumophila
      • Detecting Tuberculosis Through Rapid Diagnostic Tests
      • How the Technique Works
      • Limitations
    • Sexually Transmitted Diseases (STDs)
      • HIV
      • HTLV-1 Testing
      • Hepatitis Testing
    • Chlamydia DNA Probes
    • Detection of Intestinal Parasites
      • Entamoeba Histolytica
      • Salmonella
  • Identity/Forensics
    • DNA Profiling: A Key Forensic Tool
    • DNA-Based Forensic Diagnostics
    • Tracing Human Origins
  • Genetic Predisposition
  • Molecular HLA Testing
    • Human Leukocyte Antigen (HLA) Typing
  • Cancer Testing
    • Cancer: A Deadly Disease Afflicting Millions
    • Slow Detoxifiers: Potential Cancer Candidates
    • Improving Cancer Surgery Through Diagnostic Tests
    • Types of Cancer
      • Chronic Lymphocytic Leukemia (CLL)
      • Breast Cancer
      • PCR Screening Technology for Breast Cancer
      • Eye Cancers
      • DNA Probes to Detect Retinoblastoma
      • Others
    • The Ames test
  • Genetic Testing
  • Other Diagnostic Applications
    • Cystic Fibrosis
    • Malaria Testing
    • Detection of Multidrug Resistance
    • Bacterial Resistance to Antibiotics
    • DNA Probes for Agriculture

4. PRODUCT INTRODUCTIONS/INNOVATIONS

  • LifeTechnologies Launches Applied Biosystems AutoMate Express™
  • OralDNA Labs™ Launches Two Dental Molecular Tests

5. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVE BUILDER

  • Luminex Molecular Introduces New xTAG™ Respiratory Viral Panel
  • Gen-Probe Introduces Aptima HPV Assay in Europe
  • Genzyme Genetics Introduces Prenatal Diagnosis and Carrier Testing
  • Affymetrix Launches New Cytogenetic Solution
  • Genekam Biotech Develops New Commercial DNA-Test to Detect Bird Flu
  • Seegene Launches Innovative DNA Test to Detect HPVs
  • deCODE Introduces deCODE T2
  • InterGenetics Introduces OncoVue
  • bioMerieux Unveils VIDAS C
  • bioMerieux Unveils NucliSENS EasyQ HPV
  • Applied Biosystems Launches SOLiD System
  • bioMerieux Introduces VIDAS® NT-proBNP
  • Abbott Molecular Rolls Out Six DNA Probes
  • PerkinElmer Launches Two New Multiplexing Platforms for Genomic Research
  • Kreatech Introduces First Complete Whole Genome Amplification Kit
  • Relative Genetics Introduces DNA Testing Services
  • Sorenson Launches Over-the-counter Paternity Test Kits
  • Kimball Genetics Introduces Warfarin Sensitivity DNA Test
  • bioMerieux Introduces TEMPO EB
  • Gen-Probe Launches PCA3 Assay
  • Genzyme Launches New KRAS Mutation Analysis
  • BD Launches New BD Viper™ System for Automating Molecular Diagnostic Testing Process
  • Affymetrix Unveils New GeneChip® Scanner with Higher Capacity Scanning
  • Genzyme Introduces EGFR Mutation Assay for Detecting Mutations

6. RECENT INDUSTRY ACTIVITY

  • Danaher Acquires Beckman Coulter
  • QIAGEN Partners with Genome Diagnostics
  • ZyGEM Snaps Up MicroLab Diagnostics
  • Metropolis Healthcare Partners with DDC
  • China Medical Technologies Obtains SFDA Approval
  • Nanobac Inks Merger Agreement with Eureka Genomics
  • Genzyme Enters into Licensing Agreement with Moffitt Cancer Center
  • Xceed Molecular Offers Gen-Probe License for Flow-Thru Chip® Technology
  • Dako Denmark's TOP2A FISH pharmDx Receives FDA Approval
  • Roche Diagnostics Receives Approval for Elecsys Anti-HCV Assay
  • bioMerieux and FIND Ink Memorandum of Understanding
  • BD Establishes Second Production Facility in China
  • Shanghai Kehua Bio-engineering and bioMerieux Establish Joint Venture
  • Quidel to Enter into Alliance with bioMerieux
  • Beckman Coulter Bags Rights to Hepatitis C Virus Test from Siemens
  • Affymetrix Enters into Partnership with Pathwork Diagnostics
  • Luminex Signs Distribution and Sales Agreement with Abbott
  • Gen-Probe to Acquire Innogenetics
  • Biocept to Introduce I.D.Rh(D)
  • DNA Testing Systems and DNAPrint Genomics Sign Sales Agreement

7. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER

  • Siemens Acquires Dade Behring
  • Sorenson Genomics Acquires Identigene
  • BioServe Takes Over Genomics Collaborative
  • Illumina Acquires Solexa
  • QIAGEN to Merge With eGene
  • NorDiag Acquires Genpoint
  • Cepheid Takes Over Sangtec Molecular Diagnostics
  • 3M Enters into Collaboration with Gen-Probe
  • Luminex Corporation Completes Acquisition of Tm Bioscience
  • Ventana Medical Systems and C-Path to Collaborate with NCI and FDA
  • Ipsen and bioMerieux Enter into Theragnostics Agreement
  • Celera Acquires Atria Genetics
  • Celera Acquires Berkeley HeartLab
  • Beckman Coulter Enters into Partnership
  • Affymetrix Partners with IPSOGEN for In-Vitro Diagnostic Cancer Testing
  • Ventana Medical Systems Collaborates with Genentech
  • Siemens Medical Solutions Acquires Bayer's Diagnostic Division
  • Orchid Cellmark Acquires ReliaGene Technologies
  • GATC Enters into Collaboration for Developing DNA-based Diagnostic Test
  • Genetic Solutions and Catapult Merge to Establish Catapult Genetics
  • Grant Life Sciences Signs MoU with Alphagenics Diaco Biotechnologies
  • Gen-Probe and Millipore Ink Agreement to Market MTC-NI Test
  • QIAGEN Acquires Digene Corporation
  • BD Diagnostics and Quest Diagnostics Sign Agreement for BD Viper™ System
  • Enzo Biochem Plans to Produce Single Copy DNA Probes
  • Affymetrix Signs Two Agreements with Sysmex
  • Affymetrix and Partners HealthCare Enter into Collaboration
  • Affymetrix and Epigenomics Enter into an Agreement
  • Roche Introduces Elecsys TORCH Assays
  • QIAGEN to Take Over Gentra
  • LGC Acquires AGOWA to Extend German Operations
  • ENZ Receives Patent for Phosphate Labeling for Medical Research & DNA Diagnostic Products
  • TMC Achieves CE Mark for its Tag-It Cystic Fibrosis Test Kit
  • Toshiba Licenses Electrochemical Detection Technology to Antara
  • Affymetrix Licenses Multiple Patents to Invitrogen
  • Abbott Enters into Agreement with ALSI for Licensing ProGRP Biomarker
  • QIAGEN in Protein Crystallography Co-Marketing Agreement with ActiveSight
  • Warnex Acquires Pro-DNA Diagnostic
  • Celera Genomics Gains Complete Ownership of Celera Diagnostics
  • Gen-Probe Licenses Exclusive Rights for Diagnostic Tests Development from University of Michigan
  • QIAGEN Enters into Licensing Agreement with Applied Biosystems for Real-Time PCR Technologies
  • IGC Collaborates with Roche for Cancer Biomarker Discovery
  • Affymetrix Acquires ParAllele BioScience
  • QIAGEN Enters into Distribution Agreement with Osmetech Molecular Diagnostics
  • GlaxoSmithKline Acquires Canada-Based ID Biomedical Corp.
  • Gen-Probe Obtains FDA Approval for Marketing APTIMA
  • Gen-Probe Signs Purchasing Agreement with Roche
  • MP Biomedicals Acquires Qbiogene
  • Roche Diagnostics Receives FDA Approval for AmpliChip CYP450 Test
  • Ventana Launches ISH Tests

8. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Molecular (US)
  • Affymetrix, Inc. (US)
  • Becton, Dickinson & Company (US)
  • Beckman Coulter, Inc. (US)
  • bioMerieux (France)
  • Celera Group (US)
  • Gen-Probe Incorporated (US)
  • Genzyme Corporation (US)
  • Luminex Molecular Diagnostics (Canada)
  • QIAGEN (US)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthcare Diagnostics, Inc. (US)

9. GLOBAL MARKET PERSPECTIVE

    • Table 1: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 2: World Historic Review for DNA Probes-based Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 3: World 15-Year Perspective for DNA Probes-based Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 4: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics (Infectious Disease Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 5: World Historic Review for DNA Probes-based Diagnostics (Infectious Disease Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 6: World 15-Year Perspective for DNA Probes-based Diagnostics (Infectious Disease Diagnosis) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 7: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics (Cancer Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 8: World Historic Review for DNA Probes-based Diagnostics (Cancer Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 9: World 15-Year Perspective for DNA Probes-based Diagnostics (Cancer Diagnosis) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 10: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics (Genetic Predisposition Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 11: World Historic Review for DNA Probes- based Diagnostics (Genetic Predisposition Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 12: World 15-Year Perspective for DNA Probes- based Diagnostics (Genetic Predisposition Diagnosis) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 13: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics (Identity/Forensics Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 14: World Historic Review for DNA Probes- based Diagnostics (Identity/Forensics Diagnosis) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 15: World 15-Year Perspective for DNA Probes-based Diagnostics (Identity/Forensics Diagnosis) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 16: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics (Molecular HLA Testing) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 17: World Historic Review for DNA Probes-based Diagnostics (Molecular HLA Testing) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 18: World 15-Year Perspective for DNA Probes-based Diagnostics (Molecular HLA) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 19: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics in Others Types of Diagnosis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 20: World Historic Review for DNA Probes-based Diagnostics in Others Types of Diagnosis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 21: World 15-Year Perspective for DNA Probes- based Diagnostics in Others Types of Diagnosis by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • DNA-Based Diagnostic and Test Market: Progress towards a New Phase
    • DNA-Based Diagnostic Tests Picks Up Pace in New Streams
    • Rise of DNA-Based Home Testing Kits Market
    • Focus on Select Key Players
  • B. Market Analytics
    • Table 22: The US Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 23: The US Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 24: The US 15-Year Perspective for DNA Probes- based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analytics
    • Table 25: Canadian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 26: Canadian Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 27: Canadian 15-Year Perspective for DNA Probes-based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

3. JAPAN

  • Market Analytics
    • Table 28: Japanese Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 29: Japanese Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 30: Japanese 15-Year Perspective for DNA Probes-based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4. EUROPE

  • Market Analytics
    • Table 31: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 32: European Historic Review for DNA Probes- based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 33: European 15-Year Perspective for DNA Probes-based Diagnostics by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
    • Table 34: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 35: European Historic Review for DNA Probes- based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 36: European 15-Year Perspective for DNA Probes-based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analytics
    • Table 37: French Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 38: French Historic Review for DNA Probes- based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 39: French 15-Year Perspective for DNA Probes- based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for 2003, 2011 & 2017 (includes correspondingGraph/Chart)

4b. GERMANY

  • Market Analytics
    • Table 40: German Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 41: German Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 42: German 15-Year Perspective for DNA Probes-based Diagnostics by Application Area Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analytics
    • Table 43: Italian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 44: Italian Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 45: Italian 15-Year Perspective for DNA Probes- based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • Market Analytics
    • Table 46: The UK Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 47: The UK Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 48: The UK 15-Year Perspective for DNA Probes- based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4e. REST OF EUROPE

  • Market Analytics
    • Table 49: Rest of European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 50: Rest of European Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 51: Rest of European 15-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • Market Analytics
    • Table 52: Asia-Pacific Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 53: Asia-Pacific Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 54: Asia-Pacific 15-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, dentity/ Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analytics
    • Table 55: Latin American Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 56: Latin American Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/ Forensics, Molecular HLA Testing, and Others Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 57: Latin American 15-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, dentity/ Forensics, Molecular HLA Testing, and Others Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Show More
Pricing